# Arsenous Acid for Refractory Triple-Negative Breast Cancer

> **NCT06678048** · PHASE2 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 12 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Arsenous Acid plus Chemotherapy

## Key facts

- **NCT ID:** NCT06678048
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-23
- **Primary completion:** 2026-04-22
- **Final completion:** 2026-10-23
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06678048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06678048, "Arsenous Acid for Refractory Triple-Negative Breast Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06678048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*